Eton Pharmaceutical Announces New Development Program ET-900 Evaluating Mecasermin Injection For Treatment Of Infantile And Epileptic Spasms; Plans To Dose First Patient In Q1 2027

Benzinga

2026.11.02 11:52 (GMT+0)

Benzingaで開く